Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Approved as a once-weekly GLP-1 receptor agonist for chronic weight management in adults with obesity or overweight-related health conditions, Wegovy entered the India Semaglutide market ahead of its patent expiry to counter rising competition from Eli Lillys Mounjaro
3.1 Roche / Zealand (Petrelintide Amylin Analog) Deal: On March 12, 2025, Roche licensed petrelintide (CT-388) from Denmarks Zealand Pharma for obesity
Enjoying a cheat meal occasionally can help you stick to your plan long-term without feeling deprived
From your first appointment to your maintenance phase, well make sure your plan is working for your body, your lifestyle, and your goals
US$ 20.30
US$ 21.99
US$ 21.04
US$ 22.69
